Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

UCB: Clinical Trials & FDA Approval Profile

UCB (Brussels, BE / Atlanta, GA) sponsors 86 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 22 active protocols (14 recruiting now), 49 completed protocols, and 30 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)17.4%
Median Closed Enrollment vs National (145 pts)111 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for UCB
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)86
Active Pipeline (Recruiting Now)22 (14)
Completed vs Stopped Early49 / 15 (17.4%)
Median Closed Actual Enrollment111 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals30 (6 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With UCB
Hospital Research SiteLocationShared Protocols
UCI Health and Chao Family Comprehensive Cancer CenterOrange, CA2
Ohio State University Comprehensive Cancer CenterColumbus, OH2

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by UCB
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT04115293Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia GravisPhase IIICOMPLETED
NCT04025632Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing MyopathyPhase IITERMINATED

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for UCB across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the UCB Interactive Dossier, benchmark peers in Immunology, Rheumatology, and Dermatology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI